Core Viewpoint - The company, ChipLink Integrated Circuit Manufacturing Co., Ltd., is undergoing a name change and has recently experienced a decline in stock price since its IPO, which has led to a state of underperformance in the market [1][2]. Group 1: Company Name Change and Stock Performance - The company announced a change in its Chinese name from "绍兴中芯集成电路制造股份有限公司" to "芯联集成电路制造股份有限公司," with the stock abbreviation changing from "中芯集成" to "芯联集成" effective December 6, 2023 [1]. - As of June 12, 2023, the stock price closed at 4.52 yuan, reflecting a decline of 1.31% [1]. - The stock reached a peak price of 6.96 yuan on its first trading day but is currently in a state of decline [2]. Group 2: IPO and Fundraising Details - The company completed its IPO on May 10, 2023, issuing 169,200,000 shares initially, with a total fundraising amount of 962,748,000 yuan before the exercise of the over-allotment option [2][3]. - After fully exercising the over-allotment option, the total number of shares issued increased to 194,580,000, raising a total of 1,107,160,200 yuan [2][4]. - The net proceeds from the IPO, after deducting issuance costs, were 937,276,550 yuan before the over-allotment and 1,078,341,700 yuan after [2][4]. Group 3: Use of Proceeds - The company plans to use the raised funds for projects including the technological transformation of MEMS and power device chip manufacturing and packaging testing production bases, as well as for working capital [2].

深交所项目进度信息显示，四川能源发展集团有限责任公司150亿元小公募债项目状态更新为"已受 理"，受理日期为2025年6月11日。募集说明书申报稿显示，本次债券的募集资金在扣除发行费用后，将 用于生产性支出，具体包括偿还债务、补充流动资金、项目投资、股权投资或资产收购等符合国家法律 法规要求的用途，具体用途根据发行人资金需求情况确定。 | 债券名称 | 四川能源发展集团有限责任公司2025年面向专业投资者公开发行公司债券 | | --- | --- | | 债券类别 | 小公墓 | | 申报规模(亿元) | 150.00 | | 发行人 | 四川能源发展集团有限责任公司 | | 地区 | 四川 | | 承销商/管理人 | 中信证券股份有限公司,国泰海通证券股份有限公司,广发证券股份有限公司,中信建 投证券股份有限公司,招商证券股份有限公司,华泰联合证券有限责任公司,中国国际 金融股份有限公司,兴业证券股份有限公司 | | 项目状态 | 已受理 | | 交易所确认文件文号 | | | 受理日期 | 2025-06-11 | | 更新日期 | 2025-06-11 | ...

证券代码： 600566 证券简称： 济川药业 公告编号： 2025-038 湖北济川药业股份有限公司 关于变更持续督导保荐代表人的公告 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述 或者重大遗漏，并对其内容的真实性、准确性和完整性承担法律责任。 湖北济川药业股份有限公司（以下简称"公司"）于近日收到华泰联合证券 有限责任公司（以下简称"华泰联合证券"）出具的《华泰联合证券有限责任公 司关于更换湖北济川药业股份有限公司 2020 年向特定对象发行股票持续督导保 荐代表人的函》,华泰联合证券作为公司 2020 年向特定对象发行股票的保荐机构， 原指定龙伟先生、周小金先生担任该项目的保荐代表人负责持续督导工作,持续督 导期至 2021 年 12 月 31 日止。鉴于本次发行的募集资金尚未使用完毕，华泰联合 证券仍对募集资金使用情况继续履行持续督导义务。 现因龙伟先生工作调动，不能继续担任持续督导期的保荐工作。为保证持续 督导工作的有序进行，华泰联合证券委派保荐代表人俎春雷先生（简历附后）接 替龙伟先生履行持续督导职责。 特此公告。 湖北济川药业股份有限公司董事会 附件:俎春雷个人简历 本次变 ...

Core Viewpoint - RoboTechnik Intelligent Technology Co., Ltd. is issuing shares to specific investors to raise funds for asset acquisition, with a total fundraising amount of approximately RMB 383.99 million, involving the issuance of 3,072,245 shares at a price of RMB 124.99 per share [1][11][12]. Group 1: Issuance Details - The issuance price is set at RMB 124.99 per share, with the total number of shares issued being 3,072,245 [5][11]. - The total amount raised from this issuance is RMB 383,999,902.55, which will be allocated to the company's asset acquisition [9][11]. - The shares issued will be subject to a six-month lock-up period starting from the listing date, which is scheduled for June 12, 2025 [5][23]. Group 2: Compliance and Approval - The issuance has received necessary approvals from the Shenzhen Stock Exchange and the China Securities Regulatory Commission, confirming compliance with relevant laws and regulations [21][22]. - The independent financial advisor has verified the compliance of the issuance process and the selection of investors, ensuring fairness and adherence to regulations [20][21]. Group 3: Financial Impact - Following the issuance, the company's total share capital will increase, which may lead to a dilution of existing shareholders' equity [24]. - The basic earnings per share and net asset value per share will be adjusted post-issuance, with the net asset value expected to rise from RMB 5.96 to RMB 7.99 [25][26].

广州越秀资本控股集团股份有限公司 2025 年面向专业投资者公开发 行公司债券（第二期）发行结果公告 本公司及其董事、监事、高级管理人员保证公告内容真实、准确和完整，并对 公告中的虚假记载、误导性陈述或者重大遗漏承担责任。 广州越秀资本控股集团股份有限公司（以下简称"发行人"）公开发行不超 过人民币 70 亿元公司债券已获得中国证券监督管理委员会证监许可〔2024〕1007 号文注册通过。根据《广州越秀资本控股集团股份有限公司 2025 年面向专业投 资者公开发行公司债券（第二期）发行公告》，广州越秀资本控股集团股份有限 公司 2025 年面向专业投资者公开发行公司债券（第二期） （以下简称"本期债券"） 发行规模为不超过 10 亿元（含 10 亿元），发行价格为每张 100 元，采取网下面 向专业机构投资者询价配售的方式。 本期债券发行时间自 2025 年 6 月 9 日至 2025 年 6 月 10 日，本期债券的发 行工作已于 2025 年 6 月 10 日结束，具体发行情况如下： 最终"25 越资 03"发行规模为 3 亿元，票面利率为 1.80%，全场认购倍数 为 5.30 倍；"25 越资 04" ...

Core Viewpoint - Water Sheep Group Co., Ltd. has announced a change in the designated sponsor representatives for its ongoing supervision of the issuance of convertible bonds, ensuring continuity in oversight despite personnel changes [1]. Group 1 - The company received a letter from Huatai United Securities regarding the replacement of the sponsor representative for the ongoing supervision of its convertible bond issuance [1]. - The original representatives, Zhang Lei Qing and Long Wei, were appointed for the supervision period ending on December 31, 2025, but Long Wei has been reassigned and will no longer serve in this role [1]. - Chen Yi has been appointed as the new sponsor representative to ensure the orderly continuation of supervision duties [1]. Group 2 - The board of directors expressed gratitude for Long Wei's contributions during his tenure as the sponsor representative [1]. - The change in sponsor representatives will not affect the ongoing supervisory work of Huatai United Securities for the company [1]. - The current sponsor representatives after the change are Zhang Lei Qing and Chen Yi [1]. Group 3 - Chen Yi, the new sponsor representative, is the director of the investment banking department at Huatai United Securities and has extensive experience in various IPOs and capital market projects, including those for Water Sheep Group and other notable companies [2].

债券简称： 债券代码：524303 广发证券股份有限公司2025年面向专业投资者 公开发行短期公司债券（第五期） 发行公告 发行人 （住所：广东省广州市黄埔区中新广州知识城腾飞一街 2 号 618 室） 牵头主承销商/债券受托管理人/簿记管理人 （住所：深圳市前海深港合作区南山街道桂湾五路 128 号前海深港基金小镇 B7 栋 401） 联席主承销商 （住所：深圳市福田区福田街道福华一路 111 号） （深圳市福田区福田街道益田路 5023 （住所：中国（上海）自由贸易试验区 号平安金融中心 B 座第 22-25 层） 商城路 618 号） 本公司及董事会全体成员保证信息披露的内容真实、准确、完整，没有虚假 记载、误导性陈述或重大遗漏。 重要事项提示 向专业投资者公开发行面值余额不超过 300 亿元（含）的短期公司债券（以下简 称"本次债券"）。 本次债券采取分期发行的方式，本期债券为本次债券的第二期发行，发行规 模不超过人民币 30 亿元（含）。本期债券名称确定为"广发证券股份有限公司 值为 100 元，发行数量不超过 3,000 万张（含），发行价格为人民币 100 元/张。 本期债券发行总规模为不超过 ...

Core Viewpoint - The company, Shenzhen Ugreen Technology Co., Ltd., is utilizing its own funds to pay personnel costs for fundraising projects and will subsequently replace these costs with equivalent amounts from raised funds, in compliance with regulatory requirements [2][5][8]. Fundraising Overview - The company has received approval from the China Securities Regulatory Commission for its initial public offering (IPO), issuing 41.5 million shares at a price of 21.21 RMB per share, raising a total of 880.215 million RMB, with a net amount of 770.218 million RMB after deducting issuance costs [2][3]. Fundraising Investment Project - The total investment amount for the fundraising projects is 1,503.7129 million RMB, with 772.2361 million RMB allocated from the raised funds [5]. Reasons for Using Own Funds - The company faces challenges in directly using raised funds for personnel costs due to regulatory requirements regarding payment accounts, necessitating the use of its own funds initially, followed by a replacement with raised funds within six months [5][6]. Management of Fund Usage - The company plans to document and manage the replacement of its own funds with raised funds through a detailed accounting process, ensuring compliance with regulations and proper record-keeping [7]. Impact on Company Operations - The decision to use own funds for personnel costs will not affect the normal implementation of fundraising projects and will not change the direction of raised funds or harm the interests of shareholders, particularly minority shareholders [6][8]. Review Procedures and Opinions - Both the board of directors and the supervisory board have approved the use of own funds for personnel costs, confirming that this action adheres to necessary decision-making processes and does not negatively impact the company or its shareholders [8][9].

中国经济网北京6月9日讯阿特斯(688472.SH)6月7日披露关于持股5%以下股东减持股份计划公告称，公 司收到股东无锡元禾重元优能创业投资合伙企业(有限合伙)(以下简称"元禾重元")出具的《减持计划告 知函》，因自身资金需求，元禾重元计划自公告披露之日起3个交易日后的3个月内，在符合法律法规规 定的减持前提下，通过集中竞价减持公司股份不超过36,882,173股，即不超过公司总股本1%；通过大宗 交易减持公司股份不超过73,764,346股，即不超过公司总股本2%。 阿特斯上市发行费用总额为27,792.86万元(行使超额配售选择权之前)；27,815.77万元(全额行使超额配售 选择权之后)。其中，中国国际金融股份有限公司、华泰联合证券有限责任公司、东吴证券股份有限公 司获得承销费及保荐费17,264.15万元。 | 股东名称 | 无锡元末重元优能创业投资合伙企业(有限合伙) | | --- | --- | | 计划减持数量 | 不超过:110.646,519 股 | | 计划减持比例 | 不超过:3% | | | 通过集中竞价减持不超过 1%; | | | 通过大宗交易减持不超过 2%。 | | 减持 ...

Group 1 - The core viewpoint of the article is that Jiangyin Huaxin Precision Technology Co., Ltd. has successfully passed the IPO review by the Shanghai Stock Exchange, marking it as the 22nd company to do so this year [1][2] - The company focuses on the research, production, and sales of precision stamping products, primarily various types of precision stamping cores and related precision stamping molds [1][2] - The company plans to publicly issue no more than 43.74 million shares, which will account for at least 25% of the total share capital after the issuance, aiming to raise approximately 711.98 million yuan for projects related to electric vehicle drive motor cores, precision stamping and mold R&D, and working capital [2][3] Group 2 - The actual controllers of the company are Guo Zhengping, Guo Yunrong, and Guo Wanrong, who collectively control 68.97% of the company's shares through Jiangyin Susong Investment Co., Ltd. [2][3] - The main questions raised during the listing committee meeting included inquiries about the stability of future operating performance, reasons for rapid revenue growth from certain clients, and the rationale behind the fundraising projects [2][3]